News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

CardioComm Solutions Inc. (CCG) Receives FDA Approval to Market the HeartCheck™ ECG Monitor as a Prescription Product



8/29/2012 9:42:48 AM

TORONTO--(BUSINESS WIRE)--CardioComm Solutions, Inc. (TSX-V: EKG) (“CardioComm Solutions” or the “Company”), a global medical provider of ECG acquisition and management software solutions, has received clearance from Health Canada for the sales and marketing of their Class II medical device for prescription based, hand-held ECG monitoring under the HeartCheck™ brand.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES